Public research preview

Scott Scott Franklin, Representative disclosure: Novo Nordisk A/S Common Stock (NVO)

Disclosed a buy transaction in Novo Nordisk A/S Common Stock (NVO). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
24/100
Signal Quality
60/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
11 Apr 2025, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
15 days

Timeline

Transaction date

27 Mar 2025

Public disclosure

11 Apr 2025

Now

Tracked today

Filing delay: 15 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
13 Jul 2026

Stock path

NVO from pre-transaction context through latest close.

Bought

27 Mar 2025 · 65.862 USD · Not public yet

System decision

Would have boughtThe strategy would have bought this signal, but the entry window has closed. Simulated entry on 11 Apr 2025 at 61.744 USD. Since entry: -20.4%. Planned exit on 10 Jun 2025 after 40 trading days.

Window closed34.85677.3USDDate27 Mar11 Apr13 JulOfficial disclosure11 AprPlanned exit61.7System buyBoughtDisclosureLatest
  • Not public yet
  • Buy window
  • Window closed
  • System buy
  • Planned exit
Observed transaction close
65.862
Observed disclosure close
61.744
Observed latest close
49.17
Pre-disclosure move
-6.3%
Post-disclosure move
-20.4%
Market-adjusted move
-47.1%
1w since disclosure
-9.9%
1m since disclosure
+4.7%
3m since disclosure
+9.7%
Pre-disclosure peak run-up
+0.6%
Retrace from peak
-6.8%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 11 Apr 2025, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerNVO
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20029132.pdf
personNameScott Scott Franklin
amountRange$1,001 - $15,000
companyNameNovo Nordisk A/S Common Stock (NVO)
publishedAt2025-04-11T00:00:00.000Z
rawDocumentIdraw-us-house-20029132-0
disclosureDate2025-04-11
transactionDate2025-03-27
transactionTypeP